[WG-HealthIDAssurance] HIAWG meets tomorrow March 17, 2022, at 2 PM ET

[Tom (Thomas) Sullivan]

+++++++++++++++++++++++++++++++++++++++++++++++++++++

Kantara Initiative is inviting you to a scheduled Zoom meeting.

Topic: Health Identity Assurance WG
Time: March 17, 2022, at 2 PM ET.

Join Zoom Meeting
https://zoom.us/j/92931210695?pwd=QTZBdVlEWWJzSFlEdzVqQUN5cDZjZz09

Meeting ID: 929 3121 0695
Passcode: 526764

One tap mobile
+13126266799,,92931210695#,,,,*526764# US (Chicago)
+16465588656,,92931210695#,,,,*526764# US (New York)

Dial by your location
        +1 312 626 6799 US (Chicago)
        +1 646 558 8656 US (New York)
        +1 301 715 8592 US (Washington DC)
        +1 346 248 7799 US (Houston)
        +1 669 900 9128 US (San Jose)
        +1 253 215 8782 US (Tacoma)
Meeting ID: 929 3121 0695
Passcode: 526764
Find your local number: https://zoom.us/u/aymQ5ozBV
++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++

Agenda:  Roll call and start recording

HIAWG participants,

Tomorrow we will update participants with the most recent information on joining the FIRE Workgroup focusing on implementation of ecommerce transactions.  Jim Kragh met with his FIRE group early this week and will give an update and we will work on creating a new joint Charter.  Here is our outdated Charter from 2019 (attached)

Also, I attended the Kantara Leadership Council today and met some new staff, along with Kay and Andrew.  I presented a summary of our work over the past few years and offered some comments on the future of these initiatives. We heard some very preliminary news about a possible Kantara relationship with some British government agencies interested in our Identity work

Tom

Thomas E Sullivan, MD

Chief Medical Strategic Officer

 DrFirst.com, Inc.

(978) 729-5075 (M)

tsul...@drfirst.com

 

Notice of Confidentiality: The information included and/or attached in this electronic mail transmission may contain confidential or privileged information and is intended for the addressee. Any unauthorized disclosure, reproduction, distribution or the taking of action in reliance on the contents of the information is prohibited. If you believe that you have received the message in error, please notify the sender by reply transmission and delete the message without copying or disclosing it.